Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RTTR

Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis

Ritter Pharmaceuticals logo

About Ritter Pharmaceuticals Stock (NASDAQ:RTTR)

Advanced Chart

Key Stats

Today's Range
$3.37
$3.89
50-Day Range
$0.45
$4.09
52-Week Range
$0.15
$1.27
Volume
45,396 shs
Average Volume
14.23 million shs
Market Capitalization
$157.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RTTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ritter Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RTTR Stock News Headlines

Dr. John D. Ritter
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Kristen Ritter
Dr. Harold K. Ritter
Denver Business Journal welcomes new tech reporter
See More Headlines

RTTR Stock Analysis - Frequently Asked Questions

Ritter Pharmaceuticals Inc (NASDAQ:RTTR) issued its quarterly earnings results on Friday, May, 1st. The biotechnology company reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.01.

Ritter Pharmaceuticals shares reverse split on Friday, March 23rd 2018.The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 22nd 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Ritter Pharmaceuticals (RTTR) raised $20 million in an initial public offering (IPO) on Wednesday, June 24th 2015. The company issued 4,000,000 shares at $5.00 per share. Aegis Capital Corp and Chardan Capital Markets served as the underwriters for the IPO and Barrington Research was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ritter Pharmaceuticals investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), APA (APA), Charles Schwab (SCHW), Genocea Biosciences (GNCA) and Hudson Technologies (HDSN).

Company Calendar

Last Earnings
5/01/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RTTR
CIK
1460702
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.13 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-162.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.67
Quick Ratio
3.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.10 per share
Price / Book
34.20

Miscellaneous

Outstanding Shares
46,153,000
Free Float
N/A
Market Cap
$157.84 million
Optionable
Not Optionable
Beta
-0.43
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:RTTR) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners